Oramed Pharmaceuticals Inc (ORMP)
2.25
-0.12
(-5.06%)
USD |
NASDAQ |
Apr 25, 12:10
Oramed Pharmaceuticals Total Assets (Quarterly): 220.55M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 220.55M |
| September 30, 2023 | 230.89M |
| June 30, 2023 | 156.31M |
| March 31, 2023 | 159.78M |
| December 31, 2022 | 161.64M |
| September 30, 2022 | 164.44M |
| June 30, 2022 | 162.29M |
| March 31, 2022 | 172.22M |
| November 30, 2021 | 182.45M |
| August 31, 2021 | 128.00M |
| May 31, 2021 | 80.49M |
| February 28, 2021 | 61.66M |
| November 30, 2020 | 40.97M |
| August 31, 2020 | 44.63M |
| May 31, 2020 | 46.16M |
| February 29, 2020 | 29.88M |
| November 30, 2019 | 31.14M |
| August 31, 2019 | 34.66M |
| May 31, 2019 | 37.43M |
| February 28, 2019 | 41.81M |
| November 30, 2018 | 43.59M |
| August 31, 2018 | 47.40M |
| May 31, 2018 | 34.66M |
| February 28, 2018 | 38.25M |
| November 30, 2017 | 41.54M |
| Date | Value |
|---|---|
| August 31, 2017 | 38.71M |
| May 31, 2017 | 39.79M |
| February 28, 2017 | 41.84M |
| November 30, 2016 | 44.93M |
| August 31, 2016 | 42.83M |
| May 31, 2016 | 36.30M |
| February 29, 2016 | 38.37M |
| November 30, 2015 | 23.88M |
| August 31, 2015 | 26.35M |
| May 31, 2015 | 22.13M |
| February 28, 2015 | 22.98M |
| November 30, 2014 | 24.56M |
| August 31, 2014 | 21.80M |
| May 31, 2014 | 22.50M |
| February 28, 2014 | 23.71M |
| November 30, 2013 | 8.006M |
| August 31, 2013 | 8.66M |
| May 31, 2013 | 4.846M |
| February 28, 2013 | 5.957M |
| November 30, 2012 | 6.825M |
| August 31, 2012 | 5.295M |
| May 31, 2012 | 2.474M |
| February 29, 2012 | 3.143M |
| November 30, 2011 | 3.903M |
| August 31, 2011 | 4.326M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
29.88M
Minimum
Feb 2020
230.89M
Maximum
Sep 2023
112.93M
Average
128.00M
Median
Aug 2021
Total Assets (Quarterly) Benchmarks
| Inogen Inc | 326.19M |
| Petros Pharmaceuticals Inc | 33.80M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 57.66M |
| Shareholders Equity (Quarterly) | 163.82M |